Table 3.
Cohort baseline characteristics according to 4-hydroxynonenal levels
Characteristic | Total | 4-Hydroxynonenal staining | P valuea | ||
---|---|---|---|---|---|
Weak | Moderate | Strong | |||
Cohort (n = 34) | 100 % | 13 (38.2 %) | 12 (35.3 %) | 12 (35.3 %) | 0.755 |
Age (years) | 64.5 ± 9.51 | 63 ± 9.8 | 63.4 ± 10.5 | 68.3 ± 7.4 | – |
Sexb | 0.657 | ||||
Men | 20 (58.8 %) | 9 (69.2 %) | 6 (50 %) | 5 (55.5 %) | 0.621 |
Women | 14 (41.2 %) | 4 (30.8 %) | 6 (50 %) | 4 (44.5 %) | 0.838 |
Tumor stagingb | 0.355 | ||||
IA | 8 (23.5 %) | 3 (23.1 %) | 2 (22.2 %) | 3 (33.3 %) | 1.000 |
IB | 13 (38.2 %) | 6 (46.1 %) | 5 (41.7 %) | 2 (22.2 %) | 0.477 |
IIA | 6 (17.7 %) | 1 (7.7 %) | 4 (33.3 %) | 1 (11.1 %) | 0.395 |
IIB | 7 (20.6 %) | 3 (23.1 %) | 1 (8.3 %) | 3 (33.3 %) | 0.720 |
Smokingb | 0.060 | ||||
Smoker | 23 (67.7 %) | 10 (76.9 %) | 5 (41.7 %) | 8 (88.9 %) | 0.467 |
Nonsmoker | 11 (32.3 %) | 3 (23.1 %) | 7 (58.3 %) | 1 (11.1 %) | 0.478 |
aChi-squared test for given probabilities with Monte Carlo simulated P values (based on 2,000 replicates)
b2D-tabulated according to the respective groups